AgmaSet®

What it is:

AgmaSet® is a clinically proven, single-ingredient nerve health and resilience formula developed by Gilad & Gilad — the research scientists who discovered agmatine's role in nerve health — delivering 900 mg of G-Agmatine® (Agmatine Sulfate) per two-capsule serving, with each capsule containing 450 mg of G-Agmatine®. G-Agmatine® is Gilad & Gilad's proprietary, analytical-grade brand of agmatine — a naturally occurring amino acid metabolite derived from the decarboxylation of L-arginine and present in small amounts in plant, fish, and meat foodstuffs — manufactured under cGMP conditions to the highest purity and quality standards as the sole active ingredient in this formula. AgmaSet® is the only agmatine-containing supplement specifically formulated and clinically studied for nerve health and resilient nerve function, protected by patents. Designed for practitioner-directed use in nerve health, sensory function, and nerve-dependent muscle strength support protocols, AgmaSet® provides a high daily intake of G-Agmatine® through a flexible loading and maintenance dosing schedule with effects reported within two to four days — and up to four to six weeks for more complex nerve health presentations.

How it works:

AgmaSet® supports nerve resilience and healthy nerve function through G-Agmatine®'s unique "molecular shotgun" multi-target mechanism — simultaneously modulating multiple key molecular mechanisms specifically critical for nervous system and peripheral nerve function, distinguishing it from single-target nerve support compounds. Agmatine is an endogenous neuromodulator synthesized in the brain and stored in neurons — serving as a small molecule that interacts with multiple receptor systems and signaling pathways simultaneously rather than through a single pharmacological target. Its primary neurological mechanisms include modulation of neurotransmitter systems through its activity as an imidazoline receptor agonist and NMDA receptor antagonist — attenuating glutamate-mediated excitotoxicity that damages nerve fibers and supporting healthy neuronal signaling thresholds; regulation of ion channel activity to support normal nerve conduction and sensory signal transmission; regulation of nitric oxide (NO) production through inhibition of nitric oxide synthase (NOS) enzymes — reducing the nitrosative stress that contributes to peripheral nerve damage while supporting the vascular nitric oxide activity relevant to nerve blood supply; modulation of the polyamine pathway — influencing spermine, spermidine, and putrescine metabolism that regulates nerve cell growth, differentiation, and repair processes; and inhibition of extracellular protein advanced glycation end-product (AGE) formation — directly addressing the glycation-mediated nerve fiber damage that is a primary mechanism in metabolic neuropathy. Through this multi-target neurological activity, AgmaSet® supports healthy sensory functions, normal nerve-dependent muscle strength, sciatic nerve health and spinal-nerve interactions, and normal glucose metabolism relevant to nerve health — preserving the quality of life functions that depend on resilient peripheral and central nerve fiber integrity.

When to use it:

AgmaSet® is appropriate for practitioner-directed use in adult clients requiring comprehensive nerve health support, including those presenting with peripheral nerve dysfunction, sensory function challenges, nerve-dependent muscle weakness, spine-related nerve health concerns, and nerve health associated with metabolic conditions including glucose dysregulation. The recommended protocol begins with a loading phase of two capsules twice daily with meals for two days; if insufficient response is observed, dosage is increased to three capsules twice daily for as long as needed. A maintenance regimen of two capsules twice daily may then be continued for ongoing nerve health support. Effects may be experienced within two to four days but may require four to six weeks depending on individual nerve health status. There are no known drug interactions, making AgmaSet® broadly compatible with concurrent pharmaceutical protocols. The only known side effects are occasional soft stool and rare mild diarrhea — manageable by taking with or after meals.